Net Deals Web Search

  1. Ad

    related to: alcon novartis samples for medical professionals jobs

Search results

  1. Results From The WOW.Com Content Network
  2. Alcon - Wikipedia

    en.wikipedia.org/wiki/Alcon

    Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. [ 3 ] [ 4 ] Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals , focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies.

  3. Ciprofloxacin/dexamethasone - Wikipedia

    en.wikipedia.org/wiki/Ciprofloxacin/dexamethasone

    In clinical trials, the median time to cessation of ear pain in Ciprodex was five days in a sample population of 909 participants. However, the clinical trial failed to demonstrate any significant benefit of using the combination of active ingredients in Ciprodex over ciprofloxacin alone, in regards to ear pain.

  4. Nepafenac - Wikipedia

    en.wikipedia.org/wiki/Nepafenac

    Nepafenac, sold under the brand name Nevanac among others, is a nonsteroidal anti-inflammatory drug (NSAID), usually sold as a prescription eye drop 0.1% solution (Nevanac) or 0.3% solution (Ilevro). It is used to treat pain and inflammation associated with cataract surgery. [3] Nepafenac is a prodrug of amfenac, an inhibitor of COX-1 and COX-2 ...

  5. Novartis - Wikipedia

    en.wikipedia.org/wiki/Novartis

    Alcon: At the time Novartis bought Alcon, they had annual sales of $6.5 billion and a net income of $2 billion. [128] In April 2019, Novartis completed the spin-off of Alcon as a separate commercial entity. [73] Sandoz: As of 2013, Sandoz has been recognized as the world's second-largest generic drug company.

  6. Novartis Completes Purchase of Alcon Majority Stake ... - AOL

    www.aol.com/news/2010-08-26-novartis-alcon-buy...

    The total cost to Novartis for the 77% stake in Alcon was $38.7 billion ($168 per share). In the deal's first phase, Novartis acquired a 25% stake in Alcon from Nestlé for $10.4 billion in July 2008.

  7. Novartis hands investors Alcon spin-off, $5 billion ... - AOL

    www.aol.com/news/novartis-hands-investors-alcon...

    Novartis plans to spin off its Alcon eye care business to shareholders and buy back up to $5 billion in stock as Chief Executive Vas Narasimhan refocuses the Swiss group on prescription drugs.

  8. Life sciences industry in Switzerland - Wikipedia

    en.wikipedia.org/wiki/Life_sciences_industry_in...

    Contents. Life sciences industry in Switzerland. The life sciences industry in Switzerland directly and indirectly employs about 135,000 people. [ 1 ] It contributes 5.7% of the gross domestic product of Switzerland and 30% of the country's exports. [ 1 ] In 2017 about 30% of Swiss exports (worth $84.8 billion) were chemical products. [ 2 ]

  9. Pharmaceutical sales representative - Wikipedia

    en.wikipedia.org/wiki/Pharmaceutical_sales...

    Pharmaceutical sales representatives or Medical sales respresentatives [1] are salespeople employed by pharmaceutical companies to persuade doctors to prescribe their drugs to patients. Drug companies in the United States spend ~$5 billion annually sending representatives to doctors, [ 2 ] to provide product information, answer questions on ...

  1. Ad

    related to: alcon novartis samples for medical professionals jobs